Organogenesis Holdings Inc. current report, 13 March 2019

Business Context and Reporting Period

Company: Organogenesis Holdings Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 13, 2019
Event: Entry into a Material Definitive Agreement (Lease) by Organogenesis Inc., a wholly owned subsidiary.

Key Financial Metrics and Obligations

This filing details a new long-term lease obligation rather than reporting period financial performance metrics (revenue, profit, cash flow).

  • Property: Approximately 43,850 square feet at 333 Providence Highway, Norwood, Massachusetts (office and laboratory use).
  • Lease Term: Initial term of 10 years commencing February 1, 2020 (Rent Commencement Date).
  • Initial Monthly Base Rent: Starts at $87,700.00 in Year 1, increasing annually to $120,587.50 in Year 10.
  • Extension Options:
    • Early extension option for 5 years (Years 11-15) with fixed rent ranging from $124,241.67 to $135,204.17.
    • Subsequent option for 10 years at fair market value.
  • Security Deposit: $526,200.00 provided via letter of credit. Reducible to $263,100.00 after 36 months from the Rent Commencement Date.
  • Additional Costs: Company responsible for operating expenses, taxes, and other lease-related expenses.

Material Changes

The filing reports the creation of a new direct financial obligation. There is no prior comparable period data provided in this document as it is a current event report regarding a specific contract execution.

Outlook, Risks, and Contingencies

Management Commentary: The filing is a standard disclosure of a material agreement and does not contain forward-looking guidance on revenue or earnings.

Risks and Contingencies:

  • Commitment Risk: The company is bound to a 10-year lease with escalating rent payments starting in 2020.
  • Liquidity Impact: Immediate cash outflow of $526,200.00 for the letter of credit.
  • Default Provisions: The reduction of the letter of credit is subject to limitations related to events of default.

Investor Verification Checklist

  • Verify the company's current cash position to ensure it can support the $526,200.00 letter of credit and future rent escalations.
  • Review the full text of Exhibit 10.1 (the Lease) for specific definitions of "operating expenses" and "taxes" to understand total occupancy costs.
  • Confirm the strategic necessity of the 43,850 square feet expansion for office and laboratory operations.
  • Monitor the company's ability to exercise the early extension option within 24 months of the Rent Commencement Date if long-term occupancy is required.